PREGABALIN
SIVEM PHARMACEUTICALS ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is PREGABALIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that PREGABALIN 225MG has been permanently discontinued (last updated June 7, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is PREGABALIN not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MYLAN-PREGABALIN
MYLAN PHARMACEUTICALS ULC
MYL-PREGABALIN
MYLAN PHARMACEUTICALS ULC
Other Products
PREGABALIN CAPSULES
LUPIN LIMITED
LYRICA
UPJOHN CANADA ULC
MAR-PREGABALIN
MARCAN PHARMACEUTICALS INC
PREGABALIN
ACTAVIS PHARMA COMPANY
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
JAMP-Pregabalin
JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules
Highest health risk
Possible match — not confirmed
PREGABALIN
Pregabalin: Affected lot may contain partially full or empty capsules.
Moderate health risk
Possible match — not confirmed
PMS-PREGABALIN
PMS-PREGABALIN: Affected lot may contain empty capsules.
Moderate health risk
Possible match — not confirmed
DIN
02403749
Strength
225MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from SIVEM PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
70MG · DIN 02299712
10MG · DIN 02447576
200MG · DIN 02385465
10MG · DIN 02451786
25MG · DIN 02451794
50MG · DIN 02451808
5MG · DIN 02385791
10MG · DIN 02385805
2.5MG · DIN 02385783
250MG · DIN 02401495
500MG · DIN 02401509
250MG · DIN 02401541